We tested the anti-tumor activity of 3C23K in in vitro assays with COV434-AMHRII used as tumor cells and monocyte-derived type 2 macrophages (MDM2) used as effector cells (Supplementary Figure 6). The gene discussed is MDM2; the disease is neoplasm.